首页> 外文期刊>Pesquisa Veterinária Brasileira >Clinical and parasitological evaluation of pour-on fluazuron and ivermectin for treating canine demodicosis
【24h】

Clinical and parasitological evaluation of pour-on fluazuron and ivermectin for treating canine demodicosis

机译:浇注氟拉隆和伊维菌素治疗犬蠕形螨病的临床和寄生虫学评估

获取原文
           

摘要

The objective of the study was to evaluate the efficacy of pour-on formulations of fluazuron and ivermectin in different therapeutic protocols for treatment of demodicosis by means of quantifying mites with skin scraping, histological and clinical evaluation in dogs. Eighteen dogs with skin scrapings positive for Demodex canis were evaluated, divided into three groups. All the animals were treated every 14 days, completing 6 treatments for each animal (days 0, 14, 28, 42, 56 and 70). In group 1, pour-on 2.5% fluazuron was used at the dose of 20mg/kg; in the group 2 pour-on 2.5% fluazuron at a dose of 20 mg/kg in association with pour-on 0.5% ivermectin at the dose of 0.6mg/kg; and in group 3, pour-on 0.5% ivermectin alone was used, at the dose of 0.6mg/kg. The treatment was evaluated and monitored through skin scrapings and clinical follow-up of the lesions every 14 days for 84 days, and through histopathological examination at the end of each treatment protocol. The success rate was defined as the percentage of dogs in each group that had negative skin scrapings after the treatment: this was 16.67% for group 1, and 50% for groups 2 and 3. The reduction in mite counts reached effectiveness of 67.66%, 88.99% and 84.29% for groups 1, 2 and 3 respectively. The Wilcoxon test showed that there was a significant difference between the number of mites before and after treatment in groups 2 and 3. The histopathological examination revealed that only group 1 showed no significant difference in the intensity of infestation between days 0 and 84. Clinically, there was no significant difference between the evaluation before and after treatment in the three groups. pour-on 2.5% fluazuron and pour-on 0.5% ivermectin were not effective for treating canine demodicosis, either in association or as single therapy, when applied every 14 days for a period of 70 days. Quantification of mites using skin scrapings and histological evaluation proved to be ineffective, either one as sole therapeutic evaluation parameters, for canine demodicosis.
机译:这项研究的目的是通过定量刮除螨虫,组织学和临床评估狗狗,来评估氟柔隆和伊维菌素的泼洒制剂在不同治疗方案中对蠕形螨病的治疗效果。评价了十八只对蠕形螨病呈阳性的皮肤刮擦的狗,分为三组。每14天对所有动物进行治疗,每只动物完成6次治疗(第0、14、28、42、56和70天)。在第1组中,以20mg / kg的剂量倒入2.5%氟尿嘧啶;在第2组中,以20 mg / kg的剂量倒入2.5%氟柔隆与以0.6mg / kg的剂量倒入0.5%伊维菌素相关;在第3组中,仅使用0.5%伊维菌素倒入,剂量为0.6mg / kg。通过刮擦皮肤和对病变进行临床随访(每14天进行84天),并在每个治疗方案结束时进行组织病理学检查,对治疗进行评估和监控。成功率定义为每组治疗后皮肤刮擦阴性的狗的百分比:第1组为16.67%,第2组和第3组为50%。螨虫计数的减少达到了67.66%,第1、2和3组分别为88.99%和84.29%。 Wilcoxon测试显示,第2组和第3组治疗前后的螨虫数量之间存在显着差异。组织病理学检查显示,只有第1组在第0天至第84天之间的侵扰强度没有显着差异。三组治疗前后的评价无明显差异。当每14天使用一次,连续70天,联合使用或单独使用时,灌注2.5%氟柔隆和灌注0.5%伊维菌素均无效。用刮ing法和组织学评估方法对螨虫进行定量证明是无效的,这两种方法都不能作为犬病的唯一治疗评估参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号